Orion Surges on Strong Q1 Results, Raises 2026 Outlook Amid Pipeline Advances
Orion posts strong Q1 with 17.8% revenue growth, 47.3% operating profit surge, and raises 2026 outlook. Pipeline advances boost investor confidence.
BAYRYclinical trialsorphan drug designation